NASDAQ · Health Information Services · USD
Omada Health, Inc. (OMDA) Stock Analysis
Omada Health, Inc. (OMDA) is a Health Information Services stock listed on NASDAQ and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
OMDA Key Statistics
As of Sep 4, 2026Trading
- Open
- $22.12
- Previous Close
- $22.29
- Day's Range
- 21.86–22.97
- 52-Week Range
- 10.28–26.92
- Volume
- 877.40K
Valuation
- Market Cap
- $1.39B
- P/E Ratio
- 33.00
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 40.94
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 4.50
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 0.69
Financials (FY)
- Revenue (FY)
- $260.21M+53.24%
- Net Income (FY)
- −$12.78M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 1.39%
- Shares Outstanding
- 61.22M
- 1-Year Return
- −4.01%
Dividend and dates
- Earnings Date
- November 5, 2026
- Avg Volume
- 1.28M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
OMDA Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +44.30% |
| 2025 (partial year) | −31.39% |
As of September 4, 2026.
OMDA Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $260.21M | −$12.78M | −4.9% |
| 2024 | $169.80M | −$47.14M | −27.8% |
| 2023 | $122.78M | −$67.51M | −55.0% |
| 2022 | $89.19M | −$72.52M | −81.3% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $260.21M | $170.94M | −$11.97M | −$12.78M | −4.9% |
| 2024 | $169.80M | $102.88M | −$43.65M | −$47.14M | −27.8% |
| 2023 | $122.78M | $69.97M | −$66.00M | −$67.51M | −55.0% |
| 2022 | $89.19M | $42.79M | −$72.35M | −$72.52M | −81.3% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
OMDA Valuation vs Health Information Services Median
Median of 53 stocks| Metric | OMDA | Health Information Services median | vs median |
|---|---|---|---|
| P/E | 33.00 | 41.13 | 20% below |
| P/S ratio | 4.50 | 2.66 | 69% above |
| Profit margin | 1.39% | 0.00% | 1.4 pts above |
Medians across 53 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
Omada Health (NASDAQ:OMDA) Combines High Growth Momentum with Breakout Setup
ChartMillJP Morgan Maintains Overweight on Omada Health, Raises Price Target to $30
BenzingaCitizens Maintains Market Outperform on Omada Health, Raises Price Target to $32
BenzingaOmada Health: Q2 Shows More Evidence Of Growth Converting Into Earnings
SeekingAlphaBaird Maintains Neutral on Omada Health, Raises Price Target to $25
BenzingaBTIG Maintains Buy on Omada Health, Raises Price Target to $35
Benzinga
All 11 articles ↓Show fewer ↑
Omada Health, Inc. (OMDA) Q2 2026 Earnings Call Transcript
SeekingAlphaOmada Health (NASDAQ:OMDA) Soars on Q2 Beat, Record Margins, and Raised Guidance
ChartMillOmada Health Raises FY2026 Sales Guidance from $322.000M-$330.000M to $334.000M-$340.000M vs $327.789M Est
BenzingaOmada Health Q2 EPS $0.08 Beats $(0.01) Estimate, Sales $87.835M Beat $80.190M Estimate
BenzingaBarclays Maintains Overweight on Omada Health, Raises Price Target to $25
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Health Information Services Stocks
Veeva Systems Inc.
$44.54B
BTSGBrightSpring Health Services, Inc.
$12.02B
TEMTempus AI, Inc.
$11.66B
HQYHealthEquity, Inc.
$7.95B
HNGEHinge Health, Inc.
$7.45B
WAYWaystar Holding Corp.
$4.81B
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
UNHUnitedHealth Group Incorporated
$356.47B








